Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 7/20 | 0.66 |
| ▸ | LTA4H | P09960 | 1/20 | 0.58 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.56 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.56 |
| ▸ | GNPAT | O15228 | 1/20 | 0.55 |
| ▸ | NPY1R | P25929 | 1/20 | 0.54 |
| ▸ | NPY2R | P49146 | 1/20 | 0.54 |
| ▸ | NPY4R | P50391 | 1/20 | 0.54 |
| ▸ | MME | P08473 | 1/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30292597 | 1.00 | OPRK1 (0.66) | OPRK1LTA4HERAP2LNPEPGNPAT | |
| SCHEMBL31138045 | 1.00 | OPRK1 (0.66) | OPRK1LTA4HERAP2LNPEPGNPAT | |
| SCHEMBL30957135 | 0.98 | OPRK1 (0.69) | OPRK1LTA4HERAP2LNPEPGNPAT | |
| SCHEMBL30957125 | 0.98 | OPRK1 (0.69) | OPRK1LTA4HERAP2LNPEPGNPAT | |
| SCHEMBL29456887 | 0.98 | OPRK1 (0.69) | OPRK1LTA4HERAP2LNPEPGNPAT | |
| SCHEMBL30957126 | 0.98 | OPRK1 (0.69) | OPRK1LTA4HERAP2LNPEPGNPAT | |
| SCHEMBL30957134 | 0.98 | OPRK1 (0.69) | OPRK1LTA4HERAP2LNPEPGNPAT | |
| SCHEMBL30957133 | 0.98 | OPRK1 (0.69) | OPRK1LTA4HERAP2LNPEPGNPAT | |
| SCHEMBL30957130 | 0.98 | OPRK1 (0.69) | OPRK1LTA4HERAP2LNPEPGNPAT | |
| SCHEMBL30957128 | 0.97 | OPRK1 (0.68) | OPRK1LTA4HERAP2LNPEPGNPAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118209671-B | Method for simultaneously determining twelve impurities in illegal lin acetate by high performance liquid chromatography | 山东齐都药业有限公司 | 2024-09-06 | — | — | CN | claimed |
| CN-118209671-A | Method for simultaneously determining twelve impurities in illegal lin acetate by high performance liquid chromatography | 山东齐都药业有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-118209671-B | Method for simultaneously determining twelve impurities in illegal lin acetate by high performance liquid chromatography | 山东齐都药业有限公司 | 2024-09-06 | — | — | CN | disclosed |
| CN-118255837-A | Method for synthesizing illegal stand | 苏州特瑞药业股份有限公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-118209671-A | Method for simultaneously determining twelve impurities in illegal lin acetate by high performance liquid chromatography | 山东齐都药业有限公司 | 2024-06-18 | — | — | CN | disclosed |
| EP-3825322-B1 | POLYPEPTIDE COMPOUND, PHARMACEUTICAL COMPOSITION, PREPARATION METHOD AND APPLICATION THEREOF | CHENGDU SINTANOVO BIOTECHNOLOGY CO LTD (CN) | 2024-03-20 | — | — | EP | disclosed |